Board of Directors

Prof. Rafael (Rafi) Beyar, an interventional cardiologist, is a former director of Rambam Health Care Campus (HCC), Professor Emeritus of Medicine and Biomedical Engineering at the Technion, and former Dean of the Technion’s Rappaport Faculty of Medicine. Beyar received an MD from Tel Aviv University, DSc in Biomedical Engineering from the Technion, and MPH from the Bloomberg School of Public Health at Johns Hopkins University, with clinical training at Rambam HCC and Johns Hopkins Cardiology. His research focuses on cardiovascular imaging, computer modeling, stents and cardiovascular robotics. As the Director General of Rambam HCC, he led the construction of the hospital's west campus, including the 2000-bed Sammy Ofer Fortified Underground Emergency Hospital, the Ruth Rappaport Children's Hospital, the Joseph Fishman Oncology Center, the Eyal Ofer Heart Hospital and the Helmsley Health Discovery Tower. Beyar founded Rambam MedTech and the MindUp Incubator (a partnership between Rambam, IBM, Medtronic, Pitango and Impact First), as well as the start-ups Instent (acquired by Medtronic) and Corindus (acquired by Siemens Healthineers). He is the recipient of multiple national and international prizes and received the Society of Scholars Medal from Johns Hopkins University. He serves as President of the International Friends Associations of Rambam and is General Partner at Alive Health Care Fund. In addition, he serves on several boards, including Rambam MedTech

Ziv Sharon has been employed at the Rambam Hospital in management positions in finance roles for three decades.
Since 2005, he has been the hospital's treasurer and its finance manager. Ziv has been a lecturer in health economics at Haifa University since 1998.

Dr. Amir Belson, is the founder of multiple medical device companies, including Neoguide Systems, Vascular Pathway, Zipline Medical, Qool Therepeutics, Radiaction Medical, Embolibe, Modular Surgical, and PAFA. Several of these companies have been acquired by major players in the medical device industry, including C.R. Bard and Stryker. Dr. Belson serves on the Board of Directors of Rambam MedTech Ltd., Plantera Lab, Relimetrics, and QT Vascular. A cum laude graduate of the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Dr. Belson completed a pediatric residency at Dana Children’s Hospital in Tel Aviv and a pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford University. In addition, he spent one year as a research fellow with the Bio-Design Innovation Program at Stanford. Belson is the author of 34 medical papers and abstracts and has more than 500 issued and pending patents to his name.

Dr. Eli Opper serves as a strategic advisor on policy in the areas of technology, R&D, investments, and innovation for companies and organizations. He is on the board of several high-tech startups, and Chairman of Club 100 of the Technion Alumni Organization. Formerly, Dr. Opper served as Chairman of Eureka, an R&D organization with over 40 member countries, and as Chief Scientist of the Ministry of Industry Trade and Labor in Israel.

Dr. Avi Weissman is the Deputy Director of Rambam Health Care Campus and Acting Director of Rambam Health Care Corporation. He has served in the past as Director of Rambam’s Ambulatory Surgery Center and as Director of Medical Operations.
After completing his medical training at the Technion’s Rappaport Faculty of Medicine (1988), Dr. Weissman completed an internship and residency at the Long Island Jewish Hospital in New York and an anesthesiology residency at the UCLA Medical Center in Los Angeles, California. He continued at UCLA for an additional fellowship in cardiothoracic anesthesia both in adults and pediatrics; on completion of his fellowship, Dr. Weissman was appointed Assistant Professor.
Dr. Weissman returned to Israel in 1997 where he was appointed a senior anesthesiologist at Rambam HCC. He became acting director of the Post Anesthesia Care Unit and was subsequently appointed Director of Anesthesia in the hospital’s Ambulatory Surgery Center. Dr. Weissman established the Acute Pain Service at Rambam, where he introduced many new and innovative protocols and modalities for acute pain care.

Keren Leshem, OCON’s CEO is a seasoned executive with over 20 years’ experience in the Pharma, MedTech and Dx industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing. She was recently dubbed as one of the three women shaping the future of women’s health by Forbes Magazine.

Prior to leading OCON Therapeutics, Ms. Leshem held various global CEO, Board and Management positions within the pharmaceutical and medical industries both in Israel and abroad.

Ms. Leshem currently sits on FemTech Lab’s admissions and advisory Board, Aspivix Switzerland Board of directors as well as LSX’s Advisory Board and is a Mentor thru the 8400 Healthtech Network.